Cytokine and autoantibody patterns in acute liver failure

References

• Aranami, T., and Yamamura, T. 2008. TH17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 57:115–120.
   PubMedGoogle Scholar
• Benghiat, F. S., Charbonnier, L. M., Vokaer, B., De Wilde, V., and Le Moine, A. 2009. Interleukin 17-producing T-helper cells in alloimmunity. Transplant. Rev. (Orlando) 23:11–18.
   PubMedGoogle Scholar
• Bosello, S., Pers, J. O., Rochas, C., Devauchelle, V., De Santis, M., Daridon, C., Saraux, A., Ferraccioli, G. F., and Youinou, P. 2007. BAFF and rheumatic autoimmune disorders: Implications for disease management and therapy. Int. J. Immunopathol. Pharmacol. 20:1–8.
   PubMed Web of Science ®Google Scholar
• Dong, C. 2009. Differentiation and function of pro-inflammatory TH17 cells. Microbes Infect. 11:584–588.
   PubMed Web of Science ®Google Scholar
• Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A., and Shapiro, A. M. 2009. Inhibition of TH17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302–1311.
   PubMed Web of Science ®Google Scholar
• Ettinger, R., Kuchen, S., and Lipsky, P. E. 2008. Interleukin 21 as a target of intervention in autoimmune disease. Ann. Rheum. Dis. 67(S3):83–86.
   Google Scholar
• Feferman, T., Aricha, R., Mizrachi, K., Geron, E., Alon, R., Souroujon, M. C., and Fuchs, S. 2009. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFNγ-inducible protein 10 (IP-10) and its receptor CXCR3. J. Neuroimmunol. 209:87–95.
   PubMed Web of Science ®Google Scholar
• Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. 2009. IL-17 and TH17 cells. Annu. Rev. Immunol. 27:485–517.
   PubMed Web of Science ®Google Scholar
• Lai Kwan Lam, Q. King, Hung Ko, O., Zheng, B. J., and Lu, L. 2008. Local BAFF gene silencing suppresses TH17-cell generation and ameliorates autoimmune arthritis. Proc. Natl. Acad. Sci. USA 105:14993–14998.
   PubMed Web of Science ®Google Scholar
• Lawrenson, R. A., Seaman, H. E., Sundstrom, A., Williams, T. J., and Farmer, R. D. 2000. Liver damage associated with minocycline use in acne: A systematic review of the published literature and pharmacovigilance data. Drug Safety 23:333–349.
   PubMed Web of Science ®Google Scholar
• Matsukawa, A., Hogaboam, C. M., Lukacs, N. W., and Kunkel, S. L. 2000. Chemokines and innate immunity. Rev. Immunogenet. 2:339–358.
   PubMedGoogle Scholar
• Matsushita, T., Hasegawa, M., Matsushita, Y., Echigo, T., Wayaku, T., Horikawa, M., Ogawa, F., Takehara, K., and Sato, S. 2007. Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases. Exp. Dermatol. 16:87–93.
   PubMed Web of Science ®Google Scholar
• Migita, K., Abiru, S., Maeda, Y., Nakamura, M., Komori, A., Ito, M., Fujiwara, S., Yano, K., Yatsuhashi, H., Eguchi, K., and Ishibashi, H. 2007. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum. Immunol. 68:586–591.
   PubMed Web of Science ®Google Scholar
• Nishioji, K., Okanoue, T., Itoh, Y., Narumi, S., Sakamoto, M., Nakamura, H., Morita, A., and Kashima, K. 2001. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin. Exp. Immunol. 123:271–279.
   PubMed Web of Science ®Google Scholar
• Nistala, K., and Wedderburn, L. R. 2009. TH17 and regulatory T-cells: Rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 48(6):602–606.
   PubMed Web of Science ®Google Scholar
• Ohteki, T. 2002. Critical role for IL-15 in innate immunity. Curr. Mol. Med. 2:371–380.
   PubMedGoogle Scholar
• Ostapowicz, G., Fontana, R. J., Schiodt, F. V., Larson, A., Davern, T. J., Han, S. H., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., Crippin, J. S., Blei, A. T., Samuel, G., Reisch, J., and Lee, W. M. (2002). Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 137:947–954.
   PubMed Web of Science ®Google Scholar
• Ouyang, W., Kolls, J. K., and Zheng, Y. 2008. The biological functions of T-helper 17 cell effector cytokines in inflammation. Immunity 28:454–467.
   PubMed Web of Science ®Google Scholar
• Peck, A., and Mellins, E. D. 2009. Breaking old paradigms: TH17 cells in autoimmune arthritis. Clin Immunol. 132(3):295–304.
   PubMed Web of Science ®Google Scholar
• Shen, F., and Gaffen, S. L. 2008. Structure–function relationships in the IL-17 receptor: Implications for signal transduction and therapy. Cytokine 41:92–104.
   PubMed Web of Science ®Google Scholar
• Song, C., Luo, L., Lei, Z., Li, B., Liang, Z., Liu, G., Li, D., Zhang, G., Huang, B., and Feng, Z. H. 2008. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 181:6117–6124.
   PubMed Web of Science ®Google Scholar
• Sutherland, A. P., Van Belle, T., Wurster, A. L., Suto, A., Michaud, M., Zhang, D., Grusby, M. J., and von Herrath, M. 2009. Interleukin-21 is required for the development of Type 1 diabetes in NOD mice. Diabetes 58:1144–1155.
   PubMed Web of Science ®Google Scholar
• Zimmerman, H. (Ed.). 1999. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar